Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
A Study to Evaluate the Safety and Immunogenicity of V710 in Adults With Kidney Disease on Hemodialysis (V710-005)(COMPLETED)
This study has been completed.
Study NCT00572910 Information provided by Merck Sharp & Dohme Corp.
First Received on December 11, 2007. Last Updated on August 9, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Staphylococcus Aureus Infection
Additional conditions recognized in this trial
Kidney Failure, Chronic
More general conditions related to this trial
Gram-Positive Bacterial Infections
Renal Insufficiency, Chronic
Interventions listed in this trial
Comparator: Placebo (PBO)
V710 Comparator: Placebo (PBO)
Sponsors listed in this trial
Merck Sharp & Dohme Corp.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers